International Archives of Allergy and Immunology
Original Paper
ARIA (Allergic Rhinitis and Its Impact on Asthma) Classification of Allergic Rhinitis Severity in Clinical Practice in FranceBousquet P.J.a · Bousquet-Rouanet L.a · Co Minh H.B.a · Urbinelli R.b · Allaert F.A.b · Demoly P.aaExploration des Allergies, Maladies Respiratoires, INSERM U454-IFR3, Hôpital Arnaud de Villeneuve, CHU de Montpellier, Montpellier, bCentre d’Evaluation et de Normalisation des Biotechnologies de Bourgogne, CEN Biotech, Département de Biostatistiques et Information Médicale, CHRU du Bocage, Dijon, France
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: July 17, 2006
Accepted: October 24, 2006
Published online: February 05, 2007
Issue release date: June 2007
Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 4
ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)
For additional information: https://www.karger.com/IAA
Abstract
Background: The Allergic Rhinitis and Its Impact on Asthma (ARIA) workshop proposes a classification of allergic rhinitis severity. It does not take into account impairment in quality of life and treatment should be adapted accordingly. Methods: Two cross-sectional surveys were designed:a spring survey, for which 1,321 practitioners enrolled 3,026 patients consulting for seasonal allergic rhinitis and an autumn-winter survey, for which 1,346 practitioners enrolled 3,507 patients consulting for perennial allergic rhinitis. Simple quality of life parameters were included and logistic regressions were performed in order to assess the impairment of quality of life. Results: The majority of the patients were experiencing an impairment on their quality of life (92.2%). Except for cough, these patients had significantly more nasal, lung and ocular symptoms. In a multivariate analysis, rhinorrhea, nasal itching, red eyes, dyspnea, change in voice, fatigue and headache were correlated to impairment of quality of life. Persistent rhinitis was associated only with subjects who expressed difficulties in reading, and intermittent rhinitis with those who had to blow their nose and who expressed an impact on their professional activities. Conclusions: The proposal of the ARIA expert panel defining the severity of allergic rhinitis based on quality of life parameters is likely to simplify daily physician practice.
© 2007 S. Karger AG, Basel
Related Articles:
References
-
Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 suppl):S147–S334.
External Resources
- Demoly P, Allaert FA, Lecasble M, Bousquet J: Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003;58:672–675.
- Bauchau V, Durham SR: Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005;60:350–353.
- Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, et al: Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006;117:158–162.
- Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J: Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006;61:693–698.
- Van Hoecke H, Vastesaeger N, Dewulf L, Sys L, van Cauwenberge P: Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy 2006;61:705–711.
- Demoly P, Allaert FA, Lecasble M: ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France. Allergy 2002;57:546–554.
- Demoly P, Allaert FA, Lecasble M, Klossek JM: ERAP, a pharmaco-epidemiologic survey on perennial allergic rhinitis in every day medical practice in France. Presse Med 2003;32:1066–1073.
- Juniper EF, Guyatt GH: Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77–83.
- Van Cauwenberge P, Lund V, Bousquet J, El Akkad T: Profiles and symptom severity of patients presenting to general practice with seasonal allergic rhinitis. Allergy 2000;55:S197.
-
Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Méchin H, Daures JP, Bousquet J: Visual analogue scales can assess the severity of rhinitis graded accroding to ARIA guidelines. Allergy, in press.
Article / Publication Details
Received: July 17, 2006
Accepted: October 24, 2006
Published online: February 05, 2007
Issue release date: June 2007
Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 4
ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)
For additional information: https://www.karger.com/IAA
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
